Navigation Links
MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015
Date:8/17/2011

DALLAS, Texas, August 17, 2011 /PRNewswire/ --

The "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)" analyzes the biochip market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for biochip market in North America, Europe, Asia, and Rest of the World.

Browse market data tables and in-depth TOC on "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)".
http://www.marketsandmarkets.com/Market-Reports/biochips-advanced-technologies-and-global-market-54.html
Early buyers will receive 10% customization on reports.

Biochips were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence seen an influx of players vying fiercely for a share of this market. The global biochips market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 Billion by 2015; growing at a CAGR of 16.7%.Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), Luminex Corporation (U.S.), Bio-Rad Laboratories (U.S.), Biacore Life Sciences by GE Healthcare (Sweden), EMD Millipore (U.S.), Life Technologies (U.S.), Perkin Elmer (U.S.), Caliper Life Sciences (U.S.), Fluidigm Corporation (U.S.), Cepheid (U.S.), Epoch Biosciences (U.S.), US Biomax (U.S.), Sigma Aldrich (U.S.), Biochain Institute, Inc. (U.S.), Origene (U.S.), Super BioChips (South Korea ), and IsuAbxis Co Ltd (Seoul, Korea).

"New product launches" and "agreements and collaborations" are the two main strategies adopted by the players to stay competitive in this market. The major applications in the market driving its growth in future include cancer diagnosis and treatment, expression profiling, and diagnostics since early detection of disease and targeted treatment options are still the unmet need of this market. There were 12.3 million new cases of cancer worldwide in 2007 and about 7.6 million deaths. These figures are estimated to rise up to 16 million new cancer diagnoses and about 10 million deaths by 2020 according to WHO & American Cancer Society.

Recently Published Reports by MarketsandMarkets


Upcoming Market Research by MarketsandMarkets


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

 

Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
2. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
3. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
4. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
5. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
6. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
7. Global bioterrorism threat analyzed for world animal health office
8. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
9. Global Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
10. Scientists pinpoint river flow associated with cholera outbreaks, not just global warming
11. Lilly Global Giving Puts Power of Philanthropy in Employees Hands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):